84 related articles for article (PubMed ID: 19892032)
1. Neuraminidase enhances the initial steps of human T-cell leukemia virus type 1 replication.
Tanaka M; Sun B; Tezuka K; Fujisawa J; Tanaka Y; Hoshino H; Miwa M
Microbes Infect; 2010 Feb; 12(2):119-25. PubMed ID: 19892032
[TBL] [Abstract][Full Text] [Related]
2. Neuraminidase from a bacterial source enhances both HIV-1-mediated syncytium formation and the virus binding/entry process.
Sun J; Barbeau B; Sato S; Tremblay MJ
Virology; 2001 May; 284(1):26-36. PubMed ID: 11352665
[TBL] [Abstract][Full Text] [Related]
3. Separate cellular localizations of human T-lymphotropic virus 1 (HTLV-1) Env and glucose transporter type 1 (GLUT1) are required for HTLV-1 Env-mediated fusion and infection.
Maeda Y; Terasawa H; Tanaka Y; Mitsuura C; Nakashima K; Yusa K; Harada S
J Virol; 2015 Jan; 89(1):502-11. PubMed ID: 25339765
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human T-cell leukemia virus type 1 replication by antisense env oligodeoxynucleotide.
Maeda N; Kawamura T; Hoshino H; Yamada N; Blackard J; Kushida S; Miyano-Kurosaki N; Yamamoto N; Makino K; Yokota T; Uchida K; Miwa M
Biochem Biophys Res Commun; 1998 Feb; 243(1):109-12. PubMed ID: 9473488
[TBL] [Abstract][Full Text] [Related]
5. Cell-free entry of human T-cell leukemia virus type 1 to mouse cells.
Feng R; Kabayama A; Uchida K; Hoshino H; Miwa M
Jpn J Cancer Res; 2001 Apr; 92(4):410-6. PubMed ID: 11346463
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of plating of human T cell leukemia virus type I and syncytium-inducing types of human immunodeficiency virus type 1 by polycations.
Haraguchi Y; Takeuchi Y; Hoshino H
AIDS Res Hum Retroviruses; 1997 Nov; 13(17):1517-23. PubMed ID: 9390751
[TBL] [Abstract][Full Text] [Related]
7. Rapid syncytium formation between human T-cell leukaemia virus type-I (HTLV-I)-infected T-cells and human nervous system cells: a possible implication for tropical spastic paraparesis/HTLV-I associated myelopathy.
Mor-Vaknin N; Turgeman H; Torgeman A; Wolfson M; Huleihel M; Aboud M
Cell Biol Int; 1998; 22(2):95-103. PubMed ID: 9878096
[TBL] [Abstract][Full Text] [Related]
8. Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I gp46 surface membrane protein among various primate T-cell lymphoma/leukemia virus isolates including those from a patient with both HTLV-I-associated myelopathy and adult T-cell leukemia.
Sherman MP; Dube S; Spicer TP; Kane TD; Love JL; Saksena NK; Iannone R; Gibbs CJ; Yanagihara R; Dube DK
Cancer Res; 1993 Dec; 53(24):6067-73. PubMed ID: 8261424
[TBL] [Abstract][Full Text] [Related]
9. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ
Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232
[TBL] [Abstract][Full Text] [Related]
10. Neuraminidase treatment of respiratory syncytial virus-infected cells or virions, but not target cells, enhances cell-cell fusion and infection.
Barretto N; Hallak LK; Peeples ME
Virology; 2003 Aug; 313(1):33-43. PubMed ID: 12951019
[TBL] [Abstract][Full Text] [Related]
11. Human T-cell leukemia virus type 1 receptor expression among syncytium-resistant cell lines revealed by a novel surface glycoprotein-immunoadhesin.
Jassal SR; Pöhler RG; Brighty DW
J Virol; 2001 Sep; 75(17):8317-28. PubMed ID: 11483777
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of chondroitin sulfate type E on the binding step of human T-cell leukemia virus type 1.
Jinno-Oue A; Tanaka A; Shimizu N; Mori T; Sugiura N; Kimata K; Isomura H; Hoshino H
AIDS Res Hum Retroviruses; 2013 Mar; 29(3):621-9. PubMed ID: 23033806
[TBL] [Abstract][Full Text] [Related]
13. In vitro cellular tropism of human T cell leukemia virus type 2.
Wang TG; Ye J; Lairmore MD; Green PL
AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1661-8. PubMed ID: 11080807
[TBL] [Abstract][Full Text] [Related]
14. Envelope is a major viral determinant of the distinct in vitro cellular transformation tropism of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2.
Xie L; Green PL
J Virol; 2005 Dec; 79(23):14536-45. PubMed ID: 16282453
[TBL] [Abstract][Full Text] [Related]
15. Conflicting effects of poly(ADP-ribose) polymerase inhibitor on cell-mediated and virion-mediated HTLV-1 infection.
Tanaka M; Tanaka K; Ida C; Oue A; Yamashita S; Yao J; Takenouchi N; Miwa M
Virus Res; 2019 Sep; 270():197653. PubMed ID: 31299194
[TBL] [Abstract][Full Text] [Related]
16. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N
J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872
[TBL] [Abstract][Full Text] [Related]
17. Expression of glucose transporter 1 confers susceptibility to human T-cell leukemia virus envelope-mediated fusion.
Coskun AK; Sutton RE
J Virol; 2005 Apr; 79(7):4150-8. PubMed ID: 15767416
[TBL] [Abstract][Full Text] [Related]
18. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.
Casseb J; de Oliveira AC; Vergara MP; Montanheiro P; Bonasser F; Meilman Ferreira C; Smid J; Duarte AJ
J Med Virol; 2008 Mar; 80(3):392-8. PubMed ID: 18205234
[TBL] [Abstract][Full Text] [Related]
19. Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load.
Kubota R; Nagai M; Kawanishi T; Osame M; Jacobson S
AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1705-9. PubMed ID: 11080814
[TBL] [Abstract][Full Text] [Related]
20. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
Gessain A; Mahieux R
Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
